InsiderTrades.com logo
5 Free Dividend Stocks for 2022
From Motley Fool   |   Ad
Could these top payout stocks be part of the greatest wealth-creating tool in history?
Learn More.

RENE Insider Trading (ReNeuron Group)

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): £49,450
Insider Selling (Last 12 Months): GBX 0

ReNeuron Group Insider Trading History Chart

This chart shows the insider buying and selling history at ReNeuron Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ReNeuron Group Share Price & Price History

Current Price: GBX 38
Price Change: ▼ Price Decrease of -4 (-9.52%)
As of 01/21/2022 01:00 AM ET

This chart shows the closing price history over time for RENE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
Apple Could Be Days Away From Shocking The World
From Legacy Research   |   Ad
The "Black Box" Device Bringing the Age of the Smartphone to an End.
Learn More

ReNeuron Group Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/20/2021Barbara StaehelinInsiderBuy43,000GBX 115£49,450
4/18/2019Christopher EvansInsiderBuy10,000GBX 229£22,900
4/11/2019John Edward BerrimanInsiderBuy80,000GBX 225£180,000
See Full Table
Insider Trading at ReNeuron Group?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for ReNeuron Group and related companies.

SEC Filings (Institutional Ownership Changes) for ReNeuron Group (LON:RENE)

ReNeuron Group logo
ReNeuron Group plc develops and sells cell-based therapies in the United Kingdom. The company engages in the development of CTX stem cell therapy candidate that is in Phase IIb clinical trial for stroke disability; and human retinal progenitor cell therapy that is in Phase I/IIa clinical trial for treating retinitis pigmentosa, a blindness-causing disease. It also developing CTX-derived exosomes, which are Nano-sized packages of information released by CTX cells. ReNeuron Group plc has a research agreement with U.S. biotechnology company in the discovery and development of novel gene silencing-based therapeutics. The company was founded in 1997 and is headquartered in Pencoed, the United Kingdom.
Read More on ReNeuron Group

Today's Range

Now: GBX 38
Low: 37.50
High: 41.42

50 Day Range

MA: GBX 84.49
Low: 38
High: 106.50

52 Week Range

Now: GBX 38
Low: 37.50
High: 153.78

Volume

411,833 shs

Average Volume

634,076 shs

Market Capitalization

£21.68 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of ReNeuron Group?

ReNeuron Group's top insider investors include:
  1. Barbara Staehelin (Insider)
Ticker Wall Street doesn’t want you to have
From Legacy Research   |   Ad
Former hedge fund manager Teeka Tiwari just released the name of his top pick for you to play this $867 trillion wrecking ball…

Details on 5 more tickers that could deliver 10X gains in the coming months as this massive financial trend picks up steam.
Click here to get the name of his top ticker